PDF
Abstract
Aim: The Barcelona Clinic Liver Score (BCLC) currently limits hepatic resection only for small, solitary tumors measuring 2-3 cm with no signs of portal hypertension (PHT) or macrovascular invasion. The aim of this study was to show the benefit of surgical resection, and to compare the peri-operative and long-term outcomes between laparoscopic liver resection (LLR) and open liver resection (OLR) for hepatocellular carcinoma (HCC) classified as intermediate stage (B) under BCLC.
Methods: From 2004 to 2013, 49 patients staged as intermediate (BCLC B) and who underwent hepatic resection was included. These patients were divided into LLR or OLR. Demographics, tumor characteristics, recurrence rates and overall survival (OS) were compared between the 2 groups.
Results: Forty-nine patients were included and grouped into LLR (n = 28) and OLR (n = 21). The average tumor number was 2 ± 1 for both groups, while the mean tumor size was 4.4 ± 1.7 cm and 5.3 ± 2.6 cm for the LLR and OLR group, respectively. When compared with OLR, LLR had lower post-operative complications (14.3% vs. 33.3%, P = 0.114), and a statistically significant shorter hospital stay than the OLR group (9 vs. 21 days, P = 0.023). The LLR group also achieved a statistically significant difference in complete R0 resection as compared with the OLR group (P = 0.016). The OS and disease-free survival (DFS) at 1, 3 and 5 years were comparable between LLR and OLR (OS: 89.1% vs. 76.2%; 70.4% vs. 55.9%; 58.6% vs. 43.5%, P = 0.583; DFS: 59.3% vs. 51.0%; 20.2% vs. 44.6%; 16.2% vs. 37.2%, P = 0.947, respectively).
Conclusion: LLR showed comparable outcomes compared to OLR in the treatment of HCC staged BCLC B. Therefore, LLR as well as OLR can be considered in selective patients in the BCLC B group.
Keywords
Hepatocellular carcinoma
/
minimally invasive surgical procedures
/
laparoscopy
Cite this article
Download citation ▾
Avril David, YoungRok Choi, Ho-Seong Han, Yoo-Seok Yoon, Jai Young Cho.
Comparison of outcomes between laparoscopic vs. open liver resection for intermediate stage hepatocellular carcinoma.
Hepatoma Research, 2018, 4: 2 DOI:10.20517/2394-5079.2017.51
| [1] |
National Comprehensive Cancer Network. Clinical practice guidelines in oncology: hepatobiliary cancers. Version 4..2017;
|
| [2] |
Lee JJ,Smoot RL,Greig PD,Wei A,Cleary SP.Laparoscopic vs open liver resection for hepatocellular carcinoma at a North American Center: a 2-to-1 matched pair analysis..HPB (Oxford).2015;17:304-10 PMCID:PMC4368393
|
| [3] |
Bruix J.Management of hepatocellular carcinoma: an update..Hepatology2011;53:1020-2 PMCID:PMC3084991
|
| [4] |
Garancini M,Nespoli S,Gianotti L.Hepatic resection beyond barcelona clinic liver cancer indication; when and how..World J Hepatol2016;8:513-19 PMCID:PMC4832093
|
| [5] |
Cipriani F,Ratti F,Tranchart H,Scuderi V,Edwin B,Dagher I,Belli G,Abu Hilal M.Laparoscopic liver resections for hepatocellular carcinoma: can we extend the surgical indication in cirrhotic patients?.Surg Endosc2017;
|
| [6] |
Mussin N,Lee KW,Choi JY,Yoon KC,Hong SK,Suh KS.The correlation between preoperative volumetry and real graft weight: comparison of two volumetry programs..Ann Surg Treat Res2017;92:214-20 PMCID:PMC5378562
|
| [7] |
Nugroho A,Lee KW,Kim H,Yoon KC,Choi YR,Yi NJ.Evaluation of donor workups and exclusions in a single-center experience of living donor liver transplantation..Liver Transpl2017;23:614-24
|
| [8] |
Han KH,Ye SL,Poon RT,Park JW,Chung JW,Cheng AL.Asian consensus workshop report: expert consensus guidelines for the management of intermediate and advanced hepatocellular carcinoma in Asia..Oncology2011;81:158-64
|
| [9] |
Torzilli G,Marconi M,Del Fabbro D,Botea F.Hepatectomy for stage B and C hepatocellular carcinoma in the Barcelona Clinic Liver Cancer classification..Arch Surg2008;143:1082-90
|
| [10] |
Kanazawa A,Shimizu S,Yamazoe S,Kubo S.Impact of laparoscopic liver resection for hepatocellular carcinoma with F4 liver cirrhosis..Surg Endosoc2013;27:2592-97
|
| [11] |
Kim H,Hong SK,Kim HS,Lee HW,Lee KW.Survival benefit of liver resection for Barcelona Clinic Liver Cancer stage B hepatocellular carcinoma..Br J Surg2017;104:1045-52
|
| [12] |
Ishizawa T,Aoki T,Inoue Y,Imamura H,Kokudo N.Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma..Gastroenterology2008;134:1908-16
|
| [13] |
Memeo R,Compagnon P,C,Laurent A.Laparoscopic vs open liver resection for hepatocellular carcinoma of cirrhotic liver: a case-control study..World J Surg2014;38:2919-26
|